Are you Dr. Wu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 27 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Yun Wu, MD is a board certified pathologist in Houston, Texas. She is currently licensed to practice medicine in Texas and New York. She is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
- Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 2003 - 2004
- University of Texas Southwestern Medical CenterResidency, Pathology-Anatomic and Clinical, 1999 - 2003
- Shanghai Medical UniversityClass of 1991
Certifications & Licensure
- TX State Medical License 2003 - 2026
- NY State Medical License 2002 - 2010
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- Margin Width and Local Recurrence in Patients with Phyllodes Tumors of the Breast.Haydee Del Calvo, Yun Wu, Heather Y Lin, Elise F Nassif, Maria A Zarzour
Annals of Surgical Oncology. 2024-11-01 - 3 citationsNuclear staining for pan-Trk by immunohistochemistry is highly specific for secretory carcinoma of breast: pan-Trk in various subtypes of breast carcinoma.Qiqi Ye, Hui Chen, Cody Han, Yan Peng, Xiao Huang
Journal of Clinical Pathology. 2024-10-20 - ASO Visual Abstract: Margin Width and Local Recurrence in Patients with Phyllodes Tumors of the Breast.Haydee Del Calvo, Yun Wu, Heather Y Lin, Elise F Nassif, Maria A Zarzour
Annals of Surgical Oncology. 2024-08-23
Press Mentions
- Students Present Their Summer Research ProjectsSeptember 13th, 2021
- AACR21 Preview: Discovery Science Driving Clinical BreakthroughsApril 5th, 2021
- Sfrp1 Protects Against Acute Myocardial Ischemia (AMI) Injury in Aged Mice by Inhibiting the Wnt/Β-catenin Signaling PathwayJanuary 19th, 2021